Results 191 to 200 of about 12,555 (213)

Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy

Drug Design, Development and Therapy, 2023
exaly  

The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause

Climacteric, 2018
Santiago Palacios, Rossella E Nappi
exaly  

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective

Microorganisms, 2020
Diletta Rosati, Mariolina Bruno, Martin Jaeger   +2 more
exaly  

VULVOVAGINAL CANDIDIASIS

InPharma, 1977
openaire   +1 more source

Global burden of recurrent vulvovaginal candidiasis: a systematic review

Lancet Infectious Diseases, The, 2018
Matthew Kneale, Jack D Sobel
exaly  

Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations

American Journal of Obstetrics and Gynecology, 1998
Jack D Sobel, Betsy Foxman
exaly  

Vulvovaginal candidiasis

2016
openaire   +1 more source

Vulvovaginal candidiasis

Journal of Midwifery & Women's Health, 2010
openaire   +2 more sources

[Vulvovaginal candidiasis].

Ryoikibetsu shokogun shirizu, 1999
T, Kubota, H, Yonemoto
openaire   +1 more source

Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis

American Journal of Obstetrics and Gynecology, 1985
Jack D Sobel
exaly